ADM, CJ CheilJedang form joint venture for feed-grade amino acid production in Americas

By Public Technologies
  • CJ CheilJedang agreed to form a joint venture with ADM to secure long-term supplies of feed-grade amino acids for livestock markets.
  • JV combines CJ’s fermentation technology with ADM’s U.S. manufacturing footprint and feedstock supply to support domestic production, especially lysine.
  • Assets include CJ plants in Iowa and Brazil, ADM’s Decatur, Illinois amino acid plant, CJ sales offices across the Americas.
  • Venture gets exclusive rights to manufacture and sell feed-grade amino acids in North and South America; CJ will hold a majority stake.
  • Launch remains subject to customary closing steps and regulatory approvals.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ADM - Archer Daniels Midland Company published the original content used to generate this news brief via Business Wire (Ref. ID: 20261002828242) on October 02, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.